RELMADA THERAPEUTICS, INC. Notes Payable, Noncurrent
RELMADA THERAPEUTICS, INC. (RLMD) had Notes Payable, Noncurrent of $3.19 million as of 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermNotesPayable · last filed 2020-03-26
- 2018-09-30: Notes Payable, Noncurrent $3.19M.
- 2018-06-30: Notes Payable, Noncurrent $2.66M.
- 2018-03-31: Notes Payable, Noncurrent $1.58M.
- 2017-12-31: Notes Payable, Noncurrent $1.28M.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2018-09-30 | $3.19M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $2.66M 10-KT · filed 2020-03-26 |
| 2018-03-31 | $1.58M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $1.28M 10-Q · filed 2018-02-12 |
| 2017-09-30 | $678.88K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |